focus -WSS

focus

author：knowledge 2025-10-01 04:13:44 - browse：43

The human gut teems with bacteria and other colorful microbes. — NIH

One of the indignities of getting older is the way your body’s defenses against microbes begin to break down, leaving you extra vulnerable to infection. Researchers studying the ways these systems change with age refer to them collectively as “immunosenescence,” or, more poetically, the “twilight of immunity.” But even as scientific understanding of the phenomenon has grown over the past decade, the forces driving it remain murky.

One theory is that it all starts in the bone marrow, where a primitive reserve of stem cells replenishes the ranks of blood and immune cells to the tune of about 500 billion new cells every day. Some of these hematopoietic stem cells, or HSCs, are more likely to become long-lived stewards of immune memory like B cells and T cells; others are more likely to give rise to blood cells and front-line immune defenders. They all work in concert to get the balance right. As people age, though, one lineage of HSCs starts to dominate, throwing the equilibrium off-kilter.

On Wednesday, a team of scientists at Stanford University and the National Institutes of Health Rocky Mountain Laboratories reported in Nature that this age-associated imbalance in HSCs is to blame for a cascade of downstream declines in immune function. And by restoring a youthful balance of these cells with injections of antibodies, they were able to rejuvenate the immune systems of older mice — enabling them to better fend off viral attacks.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Duchenne breakthrough therapy leaves behind pioneering families
Next article： Cassava reveals details — and problems — with Alzheimer's study

WSS

First Opinion Podcast: How to protect health care in times of war

Bernie Sanders bashes nonprofit hospitals over their tax breaks

Testing for cancer recurrence creates a new limbo for patients

Maker of FluMist seeks to allow at

Senate panel to vote on hospitals, PBMs, prisoner care

Medicare to cover more brain scans related to Alzheimer’s drugs

hotspot

focus

focus

Medicare proposal to cover medical devices draws a mixed reaction

Akero's treatment for NASH falls short in cirrhosis study

What does generative AI mean for health care? We asked experts

Life sciences deals on track to hit lowest point since 2017

Moonlake's readout produced a cash windfall. Risks remain

Cassava reveals details — and problems — with Alzheimer's study

Anesthesiologist group: stop taking Ozempic before surgery

Chimpanzees, like humans and whales, get menopause: Study

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Wellcome Trust names Røttingen as its new CEO

leisure time

How should state employee insurance handle Wegovy?

There’s no way to know how good AI health technologies are

Meta's Zuckerberg and Chan on track to put $50 billion into science

Biden's order seeks to regulate AI risk without stifling innovation

Telehealth options flood the market as retailers push virtual care

How should state employee insurance handle Wegovy?

knowledge

hotspot

hotspot

entertainment